Cantel Medical (CMD) Tops Q4 EPS by 25c

Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.24, $0.25 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $233.4 million versus the consensus estimate of $223.64 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• IMF chief says global economy weathered Iran war shock well
• Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
• Raymond James upgrades AMD, sees $201 billion server CPU market by 2030